- 2025-04-12 17:51KRAS G12C inhibitor 24 2735742-75-1
- 2025-04-12 17:51Tifuvirtide (T-1249) 251562-00-2
- 2025-04-12 17:512′-O-(2-Methoxyethyl)adenosine 168427-74-5
- 2025-04-12 17:51CDK12/13 ligand 1 2244986-40-9
- 2025-04-12 17:51Imidocarb dihydrochloride monohydrate
- 2025-04-12 17:511-[6-(Diethoxyphosphinyl)-2-O-(2-methoxyethyl)-β-D-ribo-hexofuranosyl]uracil
- 2025-04-12 17:51LSD1/HDAC-IN-1 3056145-98-0
- 2025-04-12 17:51N-Butyl-N-(4-hydroxybutyl)nitrosamine 3817-11-6
- 2025-04-12 17:51PLpro/RBD-IN-1 1282451-83-5
- 2025-04-12 17:51Indeglitazar (PPM 204 and PLX 204) 835619-41-5
- 2025-04-12 17:51KGP591 3018962-69-8
- 2025-04-12 17:512',3',5'-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine 1613530-52-1
- 2025-04-12 17:51Zelavespib hydrochloride (PU-H71 hydrochloride) 2095432-24-7
- 2025-04-12 17:51Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo(RGDfC)) 862772-11-0
- 2025-04-12 17:51SiR-Hoechst
- 2025-04-12 17:51MNS (NSC 170724, MDBN) 1485-00-3
- 2025-04-12 17:51E3 ligase Ligand-Linker Conjugate 41
- 2025-04-12 17:51SU-0268 (SU0268) 2210228-45-6
- 2025-04-12 17:51Deruxtecan-Eribulin
- 2025-04-12 17:51Antitumor agent-112
